NanoViricides
NNVC
26 hedge funds and large institutions have $3.74M invested in NanoViricides in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
925% more capital invested
Capital invested by funds: $365K → $3.74M (+$3.37M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
24% more funds holding
Funds holding: 21 → 26 (+5)
4.99% more ownership
Funds ownership: 3.8% → 8.79% (+5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$446K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$353K |
| 4 |
Morgan Stanley
New York
|
+$320K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$220K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$15.2K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.79K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 5 |
JP Morgan Chase
New York
|
-$1K |
NNVC Hedge Fund Activity: Q1 2020 in Review
26 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2020, worth a combined $3.74M — up 925% from $365K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NNVC positions and 6 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.27M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $220K sold.
- 26 institutional investors held NanoViricides (NNVC) as of Q1 2020, up from 21 in Q4 2019.
- Funds reported $3.74M of NanoViricides stock for Q1 2020, up 925% quarter-over-quarter.
- 12 funds opened new NanoViricides positions in Q1 2020 and 6 closed out, a net change of +6 holders.
- The largest NanoViricides buyer in Q1 2020 was Goldman Sachs, an estimated $2.27M added.
- The largest NanoViricides seller in Q1 2020 was Renaissance Technologies, an estimated $220K sold.
Based on aggregated 13F filings for Q1 2020.